Terms of Use & Legal Disclaimer

1. Open Access Disclaimer

NEXARA — International Journal of Emerging Research & Innovation (E-ISSN: Applied, Pending Assignment | DOI: 10.5281/zenodo.XXXXXX | Indexing: Applied — OpenAIRE, Google Scholar, OAJI) is an open-access academic publishing platform. All published content is made freely available under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. Readers may share, copy, redistribute, and adapt the material for any purpose, including commercial, provided appropriate credit is given.

NEXARA operates as a platform for the dissemination of scholarly work. The views, opinions, data, and conclusions expressed in published articles are solely those of the respective authors and do not constitute endorsement, verification, or approval by NEXARA, its editorial board, or its affiliates.

2. Author Responsibility & Warranties

By submitting a manuscript, the author(s) warrant and represent that:

• The work is original and has not been previously published, nor is it under consideration for publication elsewhere.
• All data, results, analyses, and conclusions are accurate and honest to the best of the author's knowledge.
• Proper attribution has been given to all sources, and the plagiarism index is below the journal's threshold (15%).
• All co-authors have reviewed and approved the submitted manuscript.
• The work does not infringe upon the intellectual property rights, privacy rights, or any other rights of any third party.
• The author's identity and institutional affiliation are genuine and verifiable.

NEXARA assumes no responsibility for the accuracy, completeness, veracity, or authenticity of any submitted or published work. Authors bear full legal and ethical responsibility for the content of their submissions.

3. Identity Verification Policy (Effective April 2026)

4. Anti-Fraud & Research Integrity Policy

NEXARA is committed to maintaining the highest standards of research integrity. The journal reserves the right to:

• Retract published papers at any time if evidence of fabrication, falsification, plagiarism, or ethical violations is identified.
• Permanently ban authors found to have engaged in fraudulent or deceptive practices.
• Report confirmed cases of research misconduct to the author's institution, funding agencies, and relevant authorities.
• Cooperate with law enforcement agencies in cases involving criminal fraud.
• Utilize AI-based plagiarism detection, authorship verification, and manuscript integrity screening tools.

All submitted manuscripts undergo rigorous screening including plagiarism checks (iThenticate/Turnitin), AI-content detection analysis, and editorial review. Papers exceeding the 15% similarity threshold are returned to authors for revision or rejected.

5. DMCA & Intellectual Property Takedown

NEXARA respects the intellectual property rights of third parties and complies with the Digital Millennium Copyright Act (DMCA) and equivalent international provisions. If you believe that content published on NEXARA infringes your copyright or intellectual property rights, you may submit a takedown notice to:

legal@nexara.org

Your notice must include: (a) identification of the copyrighted work, (b) identification of the infringing material with URL, (c) your contact information, (d) a statement of good faith belief that the use is unauthorized, and (e) a statement under penalty of perjury that the information is accurate. NEXARA will respond to valid notices within 10 business days.

6. Limitation of Liability

TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, NEXARA, ITS PUBLISHERS, EDITORS, EDITORIAL BOARD MEMBERS, REVIEWERS, AND AFFILIATES SHALL NOT BE LIABLE FOR:

• Any direct, indirect, incidental, special, consequential, or punitive damages arising from the use or inability to use this platform.
• Any errors, omissions, inaccuracies, or misrepresentations in published content.
• Any loss or damage resulting from reliance on information published on this platform.
• Any claims arising from the actions, conduct, or representations of authors, reviewers, or other third parties.
• Any unauthorized access to or alteration of user data or submissions.

This platform and all content are provided "AS IS" and "AS AVAILABLE" without warranties of any kind, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose, or non-infringement.

7. Indemnification

By submitting a manuscript or using this platform, you agree to indemnify, defend, and hold harmless NEXARA, its publishers, editors, editorial board members, reviewers, employees, agents, and affiliates from and against any and all claims, liabilities, damages, losses, costs, and expenses (including reasonable attorney's fees) arising from:

• Your submitted content or published work.
• Your violation of these Terms of Use.
• Your infringement of any third party's intellectual property or other rights.
• Any misrepresentation of your identity, credentials, or institutional affiliation.

8. Publication Ethics

NEXARA adheres to the guidelines established by the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE). Our publication ethics framework covers:

• Peer Review: All manuscripts undergo editorial screening and peer review by qualified experts in the relevant field.
• Conflicts of Interest: Authors, reviewers, and editors must disclose any conflicts of interest that could influence the work.
• Data Sharing: Authors are encouraged to make research data available for verification and reproducibility.
• Corrections & Retractions: NEXARA publishes corrections, errata, and retractions in accordance with COPE guidelines.
• Ethical Approval: Research involving human subjects or animals must have appropriate ethical committee approval.

9. Article Processing Charges (APC) & Refund Policy

NEXARA may charge Article Processing Charges (APC) to cover editorial, production, and indexing costs. The following refund policy applies:

• Before Peer Review: Full refund if the manuscript is withdrawn before assignment to reviewers.
• During Peer Review: 50% refund if the manuscript is withdrawn after reviewer assignment but before a decision is issued.
• After Acceptance: No refund once the manuscript has been accepted for publication.
• Rejected Papers: No APC is charged for rejected manuscripts.
• Fee Waivers: NEXARA offers partial or full APC waivers for authors from low-income countries (as classified by the World Bank) on a case-by-case basis. Waiver requests must be submitted at the time of manuscript submission.

All payments are processed securely. Receipts are issued electronically upon payment confirmation.

10. Retraction & Correction Policy

NEXARA follows COPE (Committee on Publication Ethics) retraction guidelines:

• Errata/Corrigenda: Minor errors that do not affect the integrity of findings will be corrected via a published erratum linked to the original paper.
• Retractions: Papers will be retracted if there is clear evidence of fabrication, falsification, plagiarism, unethical research, or serious errors that invalidate findings. Retracted papers remain on the platform with a prominent "RETRACTED" watermark and a linked retraction notice.
• Expressions of Concern: Issued when there are grounds for concern but an investigation is incomplete.

Authors are notified before retraction and given an opportunity to respond. Retraction decisions are final and made by the Editor-in-Chief in consultation with the Editorial Board.

11. Archival & Preservation

NEXARA is committed to the long-term preservation of published scholarly content:

• All published papers are deposited in Zenodo (hosted by CERN) for permanent archival and DOI resolution.
• Metadata registration with CrossRef and harvesting by OpenAIRE is being pursued for global discoverability.
• Published content remains freely accessible even if NEXARA ceases operations, through Zenodo's perpetual archival infrastructure.

12. Accessibility

NEXARA is committed to making its platform accessible to all users, including those with disabilities. We strive to comply with WCAG 2.1 Level AA guidelines. If you encounter accessibility barriers, please contact us at accessibility@nexara.org and we will make reasonable efforts to provide the information in an accessible format.

13. Governing Law & Dispute Resolution

These Terms of Use shall be governed by and construed in accordance with the laws of India. Any disputes arising from or relating to these terms or the use of this platform shall be subject to the exclusive jurisdiction of the courts of Bangalore, Karnataka, India.

Before initiating formal legal proceedings, the parties agree to attempt resolution through good-faith negotiation and, if necessary, mediation through a mutually agreed mediator.

14. Severability

If any provision of these Terms is held to be invalid, illegal, or unenforceable by a court of competent jurisdiction, such provision shall be modified to the minimum extent necessary to make it enforceable, and the remaining provisions shall continue in full force and effect.

15. Entire Agreement

These Terms of Use, together with the Privacy Policy, Author Guidelines, and any submission-specific agreements, constitute the entire agreement between you and NEXARA regarding the use of this platform and supersede all prior agreements and understandings.

16. Contact

For legal inquiries, takedown requests, or questions regarding these terms: